Unveiling the Silent Threat: An Exploration of Fungal Infections in Critical Care Environments
Keywords:
critical care, Intensive Care Unit, risk factorsAbstract
Abstract:
Fungal infections are increasingly becoming a significant concern for patients in critical condition, particularly in intensive care units (ICUs), where mortality rates often surpass those associated with bacterial infections. Patients in ICUs, frequently immunocompromised and burdened with multiple comorbidities, face heightened susceptibility to fungal pathogens. This vulnerability is compounded by prolonged hospital stays, extensive use of antibiotics, and occurrences of multiorgan system failure.
This study aims to comprehensively explore fungal infections within the critical care setting, focusing on Aspergillus, Candida, and Mucormycosis. It investigates various risk factors contributing to the development of fungal infections, ranging from immunosuppression to exposures related to healthcare settings. Diagnostic methods, including both traditional culture-based techniques and modern molecular assays, are evaluated alongside emerging prognostic indicators.
Given the ongoing advancements in antifungal treatments, timely and accurate diagnosis emerges as critical for improving patient outcomes in ICU settings. This study endeavors to equip healthcare professionals with the necessary knowledge and tools to effectively manage fungal infections in critical care environments, ultimately enhancing patient care quality and survival rates.
References
Luis Ostrosky-Zeichner 1, Mohanad Al-Obaidi 2. Invasive Fungal Infections in the Intensive Care Unit.
Parisa Badiee 1, Abdolvahab Alborzi, Mehrvash Joukar. Molecular assay to detect nosocomial fungal infections in intensive care units.
Bassetti M, Bouza E. Invasive mould infections in the ICU setting: complexities and solutions. Journal of Antimicrobial Chemotherapy. 2017 Mar;72(suppl_1):i39–47.
Viscoli C, Bassetti M, Castagnola E, Cesaro S, Menichetti F, Ratto S, et al. Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study. BMC Infect Dis. 2014 Dec;14(1):725.
Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. The Lancet Respiratory Medicine. 2018 Oct;6(10):782–92.
Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood. 2001 Mar 15;97(6):1604–10.
CDC [Internet]. Available from: [Internet]. Available from: https://www.cdc.gov/fungal/diseases/aspergillosis/symptoms.html
Faisal Khasawneh 1, Tamam Mohamad, Mahmoud K Moughrabieh, Zongshan Lai, Joel Ager, Ayman O Soubani. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome.
Taccone FS, Van Den Abeele AM, Bulpa P, Misset B, Meersseman W, Cardoso T, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care. 2015 Dec;19(1):7.
Vandewoude K, Blot S, Depuydt P, Benoit D, Temmerman W, Colardyn F, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care. 2006;10(1):R31.
Karl Dichtl 1, Johannes Wagener 2, Johannes Tschöp 3, Ludwig Ney 3. Analysis of peritoneal galactomannan for the diagnosis of Aspergillus peritonitis.
Diagnosis and Testing for Aspergillosis [Internet]. Available from: https://www.cdc.gov/fungal/diseases/aspergillosis/diagnosis.html
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. CLIN INFECT DIS. 2008 Jun 15;46(12):1813–21.
Stijn I Blot 1, Fabio Silvio Taccone, Anne-Marie Van den Abeele, Pierre Bulpa, Wouter Meersseman, Nele Brusselaers, George Dimopoulos, José A Paiva, Benoit Misset, Jordi Rello, Koenraad Vandewoude, Dirk Vogelaers; AspICU Study Investigators. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.
K L Mortensen 1, H K Johansen, K Fuursted, J D Knudsen, B Gahrn-Hansen, R H Jensen, S J Howard, M C Arendrup. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Akeesha A Shah 1, Kevin C Hazen. Diagnostic accuracy of histopathologic and cytopathologic examination of Aspergillus species.
Tong X, Liu T, Jiang K, Wang D, Liu S, Wang Y, et al. Clinical Characteristics and Prognostic Risk Factors of Patients With Proven Invasive Pulmonary Aspergillosis: A Single-Institution Retrospective Study. Front Med. 2021 Dec 23;8:756237.
Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016 Aug 15;63(4):e1–60.
Bassetti M, Righi E, De Pascale G, De Gaudio R, Giarratano A, Mazzei T, et al. How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit Care. 2014 Aug;18(4):458.
Meersseman W, Lagrou K, Maertens J, Wijngaerden EV. Invasive Aspergillosis in the Intensive Care Unit. Clinical Infectious Diseases. 2007 Jul 15;45(2):205–16.
Nivoix Y, Velten M, Letscher‐Bru V, Moghaddam A, Natarajan‐Amé S, Fohrer C, et al. Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis. CLIN INFECT DIS. 2008 Nov;47(9):1176–84.
Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clinical Microbiology and Infection. 2012 Dec;18:19–37.
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2008 Feb 1;46(3):327–60.
Herbrecht R, Greene RE, Ribaud P, Wingard JR, Chandrasekar PH, Pauw BD. Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis. The New England Journal of Medicine. 2002;
Azie N, Neofytos D, Pfaller M, Meier-Kriesche HU, Quan SP, Horn D. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. Diagnostic Microbiology and Infectious Disease. 2012 Aug;73(4):293–300.
Britton N, Yang H, Fitch A, Li K, Seyed K, Guo R, et al. Respiratory Fungal Communities are Associated with Systemic Inflammation and Predict Survival in Patients with Acute Respiratory Failure [Internet]. Intensive Care and Critical Care Medicine; 2023 May [cited 2024 Mar 6]. Available from: http://medrxiv.org/lookup/doi/10.1101/2023.05.11.23289861
Mojazi Amiri H, Frandah W, Colmer-Hamood J, Raj R, Nugent K. Risk factors of Candida colonization in the oropharynx of patients admitted to an intensive care unit. Journal de Mycologie Médicale. 2012 Dec;22(4):301–7.
Rajni E, Jain A, Gupta S, Jangid Y, Vohra R. Risk Factors for Candidemia in Intensive Care Unit: A Matched Case Control Study from North-Western India. Acta Med (Hradec Kralove, Czech Repub). 2022;65(3):83–8.
Eggimann P, Pittet D. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med. 2014 Oct;40(10):1429–48.
Cristóbal León 1, Sergio Ruiz-Santana, Pedro Saavedra, Benito Almirante, Juan Nolla-Salas, Francisco Alvarez-Lerma, José Garnacho-Montero, María Angeles León; EPCAN Study Group. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.
L Ostrosky-Zeichner 1, C Sable, J Sobel, B D Alexander, G Donowitz, V Kan, C A Kauffman, D Kett, R A Larsen, V Morrison, M Nucci, P G Pappas, M E Bradley, S Major, L Zimmer, D Wallace, W E Dismukes, J H Rex. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting.
Erami M, Raiesi O, Momen-Heravi M, Getso MI, Fakhrehi M, Mehri N, et al. Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia. Microbial Pathogenesis. 2022 May;166:105520.
León C, Ostrosky-Zeichner L, Schuster M. What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med. 2014 Jun;40(6):808–19.
Pruller F, Wagner J, Raggam RB, Hoenigl M, Kessler HH, Truschnig-Wilders M, et al. Automation of serum (1->3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia. Medical Mycology. 2014 Jul 1;52(5):455–61.
Clancy CJ, Nguyen MH. Diagnosing Invasive Candidiasis. Kraft CS, editor. J Clin Microbiol. 2018 May;56(5):e01909-17.
Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Review of Anti-infective Therapy. 2009 Dec;7(10):1201–21.
the study group Candida albicans Germ Tube Antibody Detection in Critically Ill Patients (CAGTAUCI), Pemán J, Zaragoza R, Quindós G, Alkorta M, Cuétara MS, et al. Clinical factors associated with a Candida albicansGerm Tube Antibody positive test in Intensive Care Unit patients. BMC Infect Dis. 2011 Dec;11(1):60.
Martínez-Jiménez MC, Muñoz P, Guinea J, Valerio M, Alonso R, Escribano P, et al. Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia. Medical Mycology. 2014 Apr 1;52(3):270–5.
Terraneo S, Ferrer M, Martín-Loeches I, Esperatti M, Di Pasquale M, Giunta V, et al. Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia. Clinical Microbiology and Infection. 2016 Jan;22(1):94.e1-94.e8.
Cuenca-Estrella M, Kett DH, Wauters J. Defining standards of CARE for invasive fungal diseases in the ICU. Journal of Antimicrobial Chemotherapy. 2019 Mar 1;74(Supplement_2):ii9–15.
Jorge Mora-Duarte 1, Robert Betts, Coleman Rotstein, Arnaldo Lopes Colombo, Luis Thompson-Moya, Juanita Smietana, Robert Lupinacci, Carole Sable, Nicholas Kartsonis, John Perfect; Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Betts RF, Nucci M, Talwar D, Gareca M, Queiroz‐Telles F, Bedimo RJ, et al. A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis. CLIN INFECT DIS. 2009 Jun 15;48(12):1676–84.
Ernst-Rüdiger Kuse 1, Ploenchan Chetchotisakd 2, Clovis Arns da Cunha 3, Markus Ruhnke 4, Carlos Barrios 5, Digumarti Raghunadharao 6, Jagdev Singh Sekhon 7, Antonio Freire 8, Venkatasubramanian Ramasubramanian 9, Ignace Demeyer 10, Marcio Nucci 11, Amorn Leelarasamee 12, Frédérique Jacobs 13, Johan Decruyenaere 14, Didier Pittet 15, Andrew J Ullmann 16, Luis Ostrosky-Zeichner 17, Olivier Lortholary 18, Sonja Koblinger 19, Heike Diekmann-Berndt 19, Oliver A Cornely 20; Micafungin Invasive Candidiasis Working Group. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.
Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky-Zeichner, Annette C. Reboli, Mindy G. Schuster, Jose A. Vazquez, Thomas J. Walsh, Theoklis E. Zaoutis, Jack D. Sobel. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Ostrosky-Zeichner L, Al-Obaidi M. Invasive Fungal Infections in the Intensive Care Unit. Infectious Disease Clinics of North America. 2017 Sep;31(3):475–87.
Georgios Chamilos 1, Russell E Lewis, Dimitrios P Kontoyiannis. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
Hsin-Yun Sun 1, Nina Singh. Mucormycosis: its contemporary face and management strategies.
O A Cornely 1, S Arikan-Akdagli, E Dannaoui, A H Groll, K Lagrou, A Chakrabarti, F Lanternier, L Pagano, A Skiada, M Akova, M C Arendrup, T Boekhout, A Chowdhary, M Cuenca-Estrella, T Freiberger, J Guinea, J Guarro, S de Hoog, W Hope, E Johnson, S Kathuria, M Lackner, C Lass-Flörl, O Lortholary, J F Meis, J Meletiadis, P Muñoz, M Richardson, E Roilides, A M Tortorano, A J Ullmann, A van Diepeningen, P Verweij, G Petrikkos; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.
Kwon-Chung KJ. Taxonomy of Fungi Causing Mucormycosis and Entomophthoramycosis (Zygomycosis) and Nomenclature of the Disease: Molecular Mycologic Perspectives. Clinical Infectious Diseases. 2012 Feb 1;54(suppl_1):S8–15.
G R GALE, A M WELCH. Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum.
Ferguson BJ. Mucormycosis of the nose and paranasal sinuses.
Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments: Current Opinion in Infectious Diseases. 2004 Dec;17(6):517–25.
Levy E. Isolated Renal Mucormycosis: Journal of the American Society of Nephrology.
Marin-Garcia J. Echocardiographic Midsystolic Notching of Pulmonic Valve and Hypertension. Chest. 1979 Apr;75(4):530.
Mayberry J, Rhodes J, Matthews N, Wensinck F. Serum antibodies to anaerobic coccoid rods in patients with Crohn’s disease or ulcerative colitis, and in medical and nursing staff. BMJ. 1981 Jan 10;282(6258):108–108.
Maureen M Roden 1, Theoklis E Zaoutis, Wendy L Buchanan, Tena A Knudsen, Tatyana A Sarkisova, Robert L Schaufele, Michael Sein, Tin Sein, Christine C Chiou, Jaclyn H Chu, Dimitrios P Kontoyiannis, Thomas J Walsh. Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
L Pagano, P Ricci, A Tonso, A Nosari, L Cudillo, M Montillo, A Cenacchi, L Pacilli, F Fabbiano, A Del Favero. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto).
Mark M Hammer 1, Rachna Madan 1, Hiroto Hatabu 1. Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time.
Bhatia N, Singla K, Samra T. Indian Journal of Critical Care Medicine. 2018 May;22(5):375–7.
Machouart M, Larché J, Burton K, Collomb J, Maurer P, Cintrat A, et al. Genetic Identification of the Main Opportunistic Mucorales by PCR-Restriction Fragment Length Polymorphism. J Clin Microbiol. 2006 Mar;44(3):805–10.
Fiona Senchyna1, Catherine A. Hogan1,2, Kanagavel Murugesan1, Angel Moreno1, Dora Y. Ho3, Aruna Subramanian3, Hayden T. Schwenk4, Indre Budvytiene2, Helio A. Costa1,5, Saurabh Gombar1, and Niaz Banaei1,2,. Clinical Accuracy and Impact of Plasma Cell-Free DNA Fungal PCR Panel for Non-Invasive Diagnosis of Fungal Infection.
Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of Pulmonary Zygomycosis versus Invasive Pulmonary Aspergillosis in Patients with Cancer. Clinical Infectious Diseases. 2005 Jul 1;41(1):60–6.
Ling H, Yuan Z, Shen J, Wang Z, Xu Y. Accuracy of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Identification of Clinical Pathogenic Fungi: a Meta-Analysis. Warnock DW, editor. J Clin Microbiol. 2014 Jul;52(7):2573–82.
McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ. Mold Infections of the Central Nervous System. N Engl J Med. 2014 Jul 10;371(2):150–60.
Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet Infectious Diseases. 2019 Dec;19(12):e405–21.
Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. The Lancet Infectious Diseases. 2011 Feb;11(2):142–51.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 JAP Academy Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
